Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.6.6 replaces the prior v3.6.5 on the page, indicating a minor update to the page or its associated documents.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing Revision: v3.6.4. This indicates the page has been updated to a newer version.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study page's revision label was updated from v3.6.3 to v3.6.4, signaling a new version of the record.SummaryDifference0.0%

- Check64 days agoChange DetectedA new revision entry v3.6.3 has been added in the Study Documents, replacing the previous v3.6.2. This reflects an updated version of the study protocol/document set associated with the study.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page's revision indicator was updated to v3.6.2, replacing v3.6.0. This is a metadata update and does not alter trial details, eligibility criteria, or user-facing content.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a prominent 'No longer looking for participants' notice to reflect halted recruitment; it also updates the header styling to 'Intervention/Treatment' with a revised version tag to v3.6.0, replacing the previous 'Intervention / Treatment' header and the 'Revision: v3.5.5' entry.SummaryDifference0.3%

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.